Biogen (BIIB) Current Assets (2009 - 2026)

Biogen (BIIB) has reported Current Assets for 18 consecutive years, with $9.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 20.51% year-over-year to $9.2 billion; the TTM figure through Mar 2026 stood at $9.2 billion (up 20.51% YoY), while the FY2025 annual figure was $9.0 billion, up 20.35% from the prior year.
• Current Assets came in at $9.2 billion for Q1 2026 at Biogen, up from $9.0 billion in the prior quarter.
• The five-year high for Current Assets was $10.4 billion in Q2 2023, with the low at $6.8 billion in Q1 2024.
• Average Current Assets over 5 years is $8.4 billion, with a median of $8.5 billion recorded in 2023.
• Across the five-year window, Current Assets surged 36.35% in 2022 and plunged 31.86% in 2024, its largest moves.
• Year by year, Current Assets stood at $9.8 billion in 2022, then fell by 29.94% to $6.9 billion in 2023, then gained by 8.71% to $7.5 billion in 2024, then grew by 20.35% to $9.0 billion in 2025, then climbed by 2.41% to $9.2 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $9.2 billion, $9.0 billion, and $8.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.